Prevalence of Bacterial Lower Respiratory Tract Infections at a Tertiary Hospital in Jordan

Authors

  • Nathir Obeidat
  • Isam Bsisu School of Medicine, University of Jordan
  • Faruque Parvez
  • Zafrin Islam
  • Zaina Obeidat
  • Mai Altous
  • Mohammed N. Obeidat
  • Nidaa Ababneh
  • Ayman Wahbeh
  • Randa Farah

DOI:

https://doi.org/10.3823/837

Keywords:

lower respiratory tract infections, pneumonia, Jordan, Bacterial

Abstract

Background: Lower respiratory tract infections (LRTI) are a major cause of morbidity and mortality globally. The World Health Organization (WHO) estimates that LRTI are the most common global cause of death from infectious diseases.  However, the specific etiologic agent associated with LRTI is often unknown.

Aims: We determined the bacterial infections and seasonal patterns associated with LRTI among hospitalized cases at Jordan University Hospital (JUH) for a period of five years.

Methods: We conducted a multi-year study among hospitalized patients in Jordan on LRTI-associated bacterial etiology.

Results: We found bacterial infections among 105 (21.1%) out of 495 LRTI patients. The most frequently identified bacteria in the LRTI patients were Staphylococcus aureus (7.7%) followed by Pseudomonas aeruginosa (5.1%). Most of the LRTI patients (95.2%) had at least one chronic disease and many were admitted to the Intensive Care Unit (16.8%). Of the 18 (3.64%) patients with LRTI who died at the hospital, 2 had a bacterial infection. We noticed a seasonal pattern of bacterial infections, with the highest prevalence during the winter months.

Conclusions: Our findings suggest that early identification of bacterial agents and control of chronic disease may improve clinical management and reduce morbidity and mortality from LRTI.

References

Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SR, et

al. Estimates of the global, regional, and national morbidity,

mortality, and aetiologies of lower respiratory infections in 195

countries, 1990-2016: a systematic analysis for the Global Burden

of Disease Study 2016. Lancet Infect Dis 2018; 18(11):1191-210.

File TM. Community-acquired pneumonia. Lancet 2003;

(9400):1991-2001.

Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH,

Forsung E, et al. Epidemiology and predictors of multidrugresistant

community-acquired and health care-associated

pneumonia. Antimicrob agents chemother 2014; 58(9):5262-8.

Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien

KL, Andreo F, et al. Estimating the burden of pneumococcal

pneumonia among adults: a systematic review and metaanalysis

of diagnostic techniques. PloS one 2013; 8(4):e60273.

Welte T, Torres A, Nathwani D. Clinical and economic burden

of community-acquired pneumonia among adults in Europe.

Thorax 2012; 67(1):71-9.

Woodhead M. Community-acquired pneumonia in Europe:

causative pathogens and resistance patterns. Eur Respir J Suppl

; 36:20s-7s.

Peto L, Nadjm B, Horby P, Ngan TT, van Doorn R, Van Kinh

N, et al. The bacterial aetiology of adult community-acquired

pneumonia in Asia: a systematic review. Trans R Soc Trop Med

Hyg 2014; 108(6):326-37.

Al-Ali MK, Batchoun RG, Al-Nour TM. Etiology of communityacquired

pneumonia in hospitalized patients in Jordan. Saudi

med J 2006; 27(6):813-6.

Jean SS, Hsueh PR. High burden of antimicrobial resistance in

Asia. Int J Antimicrob Agents 2011; 37(4):291-5.

Johny M, Babelly M, Al-Benwan K, Udo EE. Antimicrobial

resistance in clinical isolates of Streptococcus pneumoniae in a

tertiary hospital in Kuwait, 1997-2007: Implications for empiric

therapy. J Infect Public Health 2010; 3(2):60-6.

Brown JS. Geography and the aetiology of community-acquired

pneumonia. Respirology (Carlton, Vic) 2009; 14(8):1068-71.

Hopstaken R, Muris J, Knottnerus J, Kester A, Rinkens P, Dinant

G. Contributions of symptoms, signs, erythrocyte sedimentation

rate, and C-reactive protein to a diagnosis of pneumonia in

acute lower respiratory tract infection. Br J Gen Pract 2003;

(490):358-64.

Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC

definitions for nosocomial infections, 1988. Am J infect control

; 16(3):128-40.

Helbig JH, Uldum SA, LÃœck PC, Harrison TG. Detection of

Legionella pneumophila antigen in urine samples by the

BinaxNOW immunochromatographic assay and comparison

with both Binax Legionella Urinary Enzyme Immunoassay (EIA)

and Biotest Legionella Urin Antigen EIA. J Med Microbiol 2001;

(6):509-16.

Andreo F, Domínguez J, Ruiz J, Blanco S, Arellano E, Prat C, et

al. Impact of rapid urine antigen tests to determine the etiology

of community-acquired pneumonia in adults. Respiratory med

; 100(5):884-91.

Thorpe TC, Wilson M, Turner J, DiGuiseppi J, Willert M, Mirrett S,

et al. BacT/Alert: an automated colorimetric microbial detection

system. J clin microbiol 1990; 28(7):1608-12.

Aydemir O, Aydemir Y, Ozdemir M. The role of multiplex PCR

test in identification of bacterial pathogens in lower respiratory

tract infections. Pak J Med Sci 2014; 30(5):1011-6.

Lim W, Van der Eerden M, Laing R, Boersma W, Karalus N, Town

G, et al. Defining community acquired pneumonia severity

on presentation to hospital: an international derivation and

validation study. Thorax 2003; 58(5):377-82.

Howell MD, Donnino MW, Talmor D, Clardy P, Ngo L, Shapiro NI.

Performance of severity of illness scoring systems in emergency

department patients with infection. Acad Emerg Med 2007;

(8):709-14.

Committee BTSSoC. BTS guidelines for the management

of community acquired pneumonia in adults. Thorax 2001;

(4):1-64.

Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund

J. Etiology of community-acquired pneumonia: increased

microbiological yield with new diagnostic methods. Clin Infect

Dis 2010; 50(2):202-9.

Almaaytah A, Mukattash TL, Hajaj J. Dispensing of nonprescribed

antibiotics in Jordan. Patient preferadherence 2015;

:1389.

Al-Lahham A, Qayyas JA, van der Linden M. The Impact of the

-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal

Carriage of Streptococcus pneumoniae in Infants of Ajlun

Governorate in Jordan. Jordan J Biol Sci 2018; 11(2).

Hayes BH, Haberling DL, Kennedy JL, Varma JK, Fry AM, Vora

NM. Burden of pneumonia-associated hospitalizations: United

States, 2001-2014. Chest 2018; 153(2):427-37.

Shah BA, Singh G, Naik MA, Dhobi GN. Bacteriological and

clinical profile of Community acquired pneumonia in hospitalized

patients. Lung India: official organ of Indian Chest Society 2010;

(2):54.

Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa

J, et al. Etiology of community-acquired pneumonia: impact of

age, comorbidity, and severity. Am J Respir Crit Care Med 1999;

(2):397-405

Run Sigurethardottir N, Nielsen AB, Munck A, Bjerrum L.

Appropriateness of antibiotic prescribing for upper respiratory

tract infectionsin general practice: Comparison between

Denmark and Iceland. Scand J Prim Health Care 2015;

(4):269-74.

Lubna Y. ALjaafreha MT, Asem A. Shehabi. Otitis External

Infections Among Jordanian Patients with Emphasis on

Pathogenic Characteristics of Pseudomonas Aeruginosa Isolates.

The Open Microbiol J. 2019; 13:3-7.

Shehabi AA, Shishtawi NI, Al-lawama M. Intestinal colonization

of infants with multidrug resistant Pseudomonas aeruginos in

tertiary care center in Jordan. The International Arabic Journal

of Antimicrobial Agents 2019; 9(2)

Alsayed AR, Alzihlif M, Al Ramahi JAW. Relevance of vancomycin

suceptibility on patients outcome infected with Staphylococcus

aureus. The International Arabic Journal of Antimicrobial Agents

; 9(1)

Al Ghizawi G, Al Sulami A, Al Taher S. Profile of communityand

hospital-acquired pneumonia cases admitted to Basra

General Hospital, Iraq. East Mediterr Health J 2007 Mar-Apr;

(2):230-42.

Herrera-Lara S, Fernandez-Fabrellas E, Cervera-Juan A, Blanquer-

Olivas R. Do seasonal changes and climate influence the etiology

of community acquired pneumonia? Arch Bronconeumol 2013;

(4):140-5.

Mongardon N, Max A, Bouglé A, Pène F, Lemiale V, Charpentier

J, et al. Epidemiology and outcome of severe pneumococcal

pneumonia admitted to intensive care unit: a multicenter study.

Critcare 2012; 16(4):R155.

Cordoba E, Maduro G, Huynh M, Varma JK, Vora NM, editors.

Deaths from pneumonia-New York City, 1999-2015. Open

Forum Infect Dis 2018 Jan 16; 5(2):ofy020.

Du P, Du R, Ren W, Lu Z, Fu P. Seasonal variation characteristic of

inhalablemicrobial communities in PM2. 5 in Beijing city, China.

Sci Total Environ 2018; 610:308-15.

Cilloniz C, Ewig S, Gabarrus A, Ferrer M, Puig de la Bella Casa

J, Mensa J, et al. Seasonality of pathogens causing communityacquired

pneumonia. Respirology 2017; 22(4):778-85.

Bsisu I, Obeidat Z, Ababneh N, Altous M, Obeidat M, Amer M,

et al. The etiology of viral lower respiratory tract infections at

a tertiary hospital in Jordan over five years. The International

Arabic Journal of Antimicrobial Agents 2019; 9(2)

Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG,

Bridges CB, et al. Severe community-acquired pneumonia due

to Staphylococcus aureus, 2003-04 influenza season. Emerging

infect dis. 2006; 12(6):894.

Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G,

et al. Staphylococcus aureus community-acquired pneumonia

during the 2006 to 2007 influenza season. Ann Emerg Med

; 53(3):358-65.

Altous M, Bsisu I, Obeidat Z, Ababneh N, Obeidat M, Amer M,

et al., editors. Viral lower respiratory tract infections requiring

hospitalisation among jordanian adults. Respirology 2019:

WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA

Reed C, Kallen AJ, Patton M, Arnold KE, Farley MM, Hageman

J, et al. Infection with community-onset Staphylococcus aureus

and influenza virus in hospitalized children. Pediatr Infect Dis J

; 28(7):572-6.

Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L, et

al. Influenza-associated pediatric mortality in the United States:

increase of Staphylococcus aureus coinfection. Pediatrics 2008;

(4):805-11.

Ishiguro T, Takayanagi N, Yamaguchi S, Yamakawa H, Nakamoto

K, Takaku Y, et al. Etiology and factors contributing to the severity

and mortality of community-acquired pneumonia. Intern med

; 52(3):317-24 Total Welte T, Marre R, Suttorp N. What is

new in the treatment of community-acquired pneumonia? Med

Klin (Munich) 2006; 101(4):313-20.

Yende S, Angus DC, Ali IS, Somes G, Newman AB, Bauer D,

et al. Influence of comorbid conditions on long-term mortality

after pneumonia in older people. J Am Geriatr Soc 2007;

(4):518-25.

Feikin DR, Hammitt LL, Murdoch DR, O’brien KL, Scott JAG.

The enduring challenge of determining pneumonia etiology in

children: considerations for future research priorities. Clin infect

dis 2017; 64(suppl_3):S188-S96.

Martens P, Worm SW, Lundgren B, Konradsen HB, BenfieldT.

Serotype-specific mortality from invasive Streptococcus

pneumoniae disease revisited. BMC infect dis 2004; 4(1):21.

Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa

J, et al. Etiology of community-acquired pneumonia: impact of

age, comorbidity, and severity. Am J respir crit care med 1999;

(2):397-405.

Weinberger B, Grubeck-Loebenstein B. Vaccines for the elderly.

Clin Microbiol Infect 2012; 18:100-8.

Walters JA, Tang JNQ, Poole P, Wood-Baker R. Pneumococcal

vaccines for preventing pneumonia in chronic obstructive

pulmonary disease. Cochrane Database Syst Rev 2017 Jan 24;

:CD001390.

Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM,

et al. Community-acquired pneumonia requiring hospitalization

among US adults. N Engl J Med2015; 373(5):415-27.

Johnstone J, Majumdar SR, Fox JD, Marrie TJ. Viral infection

in adults hospitalized with community-acquired pneumonia:

prevalence, pathogens, and presentation. CHEST J 2008;

(6):1141-8.

Lieberman D, Shimoni A, Shemer-Avni Y, Keren-Naos A,

Shtainberg R, Lieberman D. Respiratory viruses in adults with

community-acquired pneumonia. CHEST J 2010; 138(4):811-6.

Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman

TM, et al. The etiology of community-acquired pneumonia in

Australia: why penicillin plus doxycyclineor a macrolide is the

most appropriate therapy. Clin Infect Dis 2008; 46(10):1513-21.

Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman

WA, van den Broek PJ, Claas EC. Improved diagnosis of the

etiology of community-acquired pneumonia with real-time

polymerase chain reaction. Clin infect dis 2005; 41(3):345-51.

Wunderink RG, Waterer GW. Community-acquired pneumonia.

N Engl J Med 2014; 370(6):543-51.

Musher DM, Thorner AR. Community-acquiredpneumonia. N

Engl J Med2014; 371(17):1619-28.

Steinman MA, Gonzales R, Linder JA, Landefeld C. CHanging

use of antibiotics in community-based outpatient practice, 1991-

Ann Intern Med 2003; 138(7):525-33. doi: 10.7326/0003-

-138-7-200304010-00008.

Kaplan V, Clermont G, Griffin MF, Kasal J, Watson RS, Linde-

Zwirble WT, et al. Pneumonia: still the old man's friend? Arch

Intern Med. 2003; 163(3):317-23.

Downloads

Published

2019-12-01

Issue

Section

Articles

Most read articles by the same author(s)